Solstice Oncology, Inc.

CIK 2116600 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Solstice Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Mar 9, 2026D0002116600-26-000002